About Christi Shaw
Christi Shaw is a director at Beam Therapeutics.
Form D filings name Christi Shaw as a director at ReAlta Life Sciences.
Christi Shaw reports to the SEC as a director or officer of 4 public companies, including Kyverna Therapeutics (KYTX), Avantor (AVTR) and Eli Lilly & (LLY).
Christi Shaw first appears on SEC filings in 2017.
Experience
This experience comes from SEC filings. The years are when the filings name Christi Shaw in the role, so the role may have started earlier or lasted longer.
BI
Beam Therapeutics Inc.
Director
2023 – 2026 · Public company (BEAM)
KI
AI
Avantor, Inc.
Director
2019 – 2023 · Public company (AVTR)
EC
Eli Lilly & Co.
SVP and Pres., Lilly Bio-Meds
2017 – 2019 · Public company (LLY)
Key Colleagues at Startups
The people Christi Shaw works with at each company, as listed on that company's latest Form D.
ReAlta Life Sciences, Inc. · Form D, May 21, 2025
AM
Andrew Miller
Director
PM
Paolo Martini
Executive officer
FG
Frank Gadams
Director
LG
Laurie Glimcher
Director
JR
John Rickman
Chief Financial Officer
DM
David Marek
Executive officer and director
MA
Mert Aktar
Director
NK
Neel Krishna
Executive officer
LW
Lewis Williams
Director
KC
Kenji Cunnion
Executive officer
ER
Emma Reeve
Director
EJ
Edward Heidt, Jr.
Director